Merck KGaA (OTCMKTS:MKKGY) Short Interest Up 6,722.2% in March

Merck KGaA (OTCMKTS:MKKGY) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 61,400 shares, a growth of 6,722.2% from the March 15th total of 900 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 285,700 shares, the short-interest ratio is currently 0.2 days.

Merck KGaA Stock Performance

Merck KGaA stock opened at $26.36 on Wednesday. Merck KGaA has a twelve month low of $24.32 and a twelve month high of $39.17. The company has a quick ratio of 0.91, a current ratio of 1.33 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $17.03 billion, a P/E ratio of 16.27, a PEG ratio of 2.05 and a beta of 0.94. The stock’s 50 day moving average is $27.96 and its 200 day moving average is $29.98.

Merck KGaA (OTCMKTS:MKKGY) last released its earnings results on Thursday, March 6th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.47 by $0.07. The firm had revenue of $5.78 billion for the quarter, compared to analysts’ expectations of $5.40 billion. Merck KGaA had a return on equity of 10.41% and a net margin of 12.89%. On average, equities research analysts predict that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.